Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glyoxalase-I Is Upregulated in Acute Cerulein-Induced Pancreatitis: A New Mechanism in Pancreatic Inflammation? | Antioxidants (Basel) | 2021 | 34679710 | PubTator, text mining | PubMed |
| Eugenol and its liposome-based nano carrier reduce anxiety by inhibiting glyoxylase-1 expression in mice. | Braz J Biol | 2021 | 34669914 | PubTator, text mining | PubMed |
| Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice. | Food Chem Toxicol | 2021 | 34656697 | PubTator, text mining | PubMed |
| Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. | Sci Rep | 2021 | 34654829 | PubTator, text mining | PubMed |
| The benefit of combining curcumin, bromelain and harpagophytum to reduce inflammation in osteoarthritic synovial cells. | BMC Complement Med Ther | 2021 | 34649531 | PubTator, text mining | PubMed |
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases. | Int J Mol Sci | 2021 | 34638532 | PubTator, text mining | PubMed |
| Spironolactone Attenuates Methylglyoxal-induced Cellular Dysfunction in MC3T3-E1 Osteoblastic Cells. | J Korean Med Sci | 2021 | 34609092 | PubTator, text mining | PubMed |
| Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis. | Front Genet | 2021 | 34603386 | PubTator, text mining | PubMed |
| Preventing Alzheimer's disease within reach by 2025: Targeted-risk-AD-prevention (TRAP) strategy. | Alzheimers Dement (N Y) | 2021 | 34584937 | PubTator, text mining | PubMed |
| Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression. | J Clin Med | 2021 | 34575195 | PubTator, text mining | PubMed |
| Normalizing HIF-1α Signaling Improves Cellular Glucose Metabolism and Blocks the Pathological Pathways of Hyperglycemic Damage. | Biomedicines | 2021 | 34572324 | PubTator, text mining | PubMed |
| Glutathione Metabolism in Plants under Stress: Beyond Reactive Oxygen Species Detoxification. | Metabolites | 2021 | 34564457 | PubTator, text mining | PubMed |
| Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples. | Transl Androl Urol | 2021 | 34532265 | PubTator, text mining | PubMed |
| Methylglyoxal attenuates isoproterenol-induced increase in uncoupling protein 1 expression through activation of JNK signaling pathway in beige adipocytes. | Biochem Biophys Rep | 2021 | 34527816 | PubTator, text mining | PubMed |
| The possible role of methylglyoxal metabolism in cancer. | J Enzyme Inhib Med Chem | 2021 | 34517737 | PubTator, text mining | PubMed |
| Identification of microRNA Signature and Key Genes Between Adenoma and Adenocarcinomas Using Bioinformatics Analysis. | Onco Targets Ther | 2021 | 34511938 | PubTator, text mining | PubMed |
| Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma. | Front Genet | 2021 | 34490047 | PubTator, text mining | PubMed |
Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients. | J Alzheimers Dis | 2021 | 34487040 | PubTator, text mining | PubMed |
| Recent Developments in Free Energy Calculations for Drug Discovery. | Front Mol Biosci | 2021 | 34458321 | PubTator, text mining | PubMed |
| The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort. | PLoS One | 2021 | 34449791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=27